Stanley Druckenmiller’s Cidara Therapeutics CDTX Stock Holding History

Stanley Druckenmiller’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-49,495	Closed	-$10.9M	–	74
2025 Q4	$10.9M	Buy	+49,495	New	+$8M	0.24%	51

Stanley Druckenmiller's CDTX Position: Q1 2026 in Review

Stanley Druckenmiller sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 49,495 shares — an estimated $10.9M sold.

Stanley Druckenmiller first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $10.9M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Stanley Druckenmiller reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Stanley Druckenmiller sold 49,495 Cidara Therapeutics shares in Q1 2026, an estimated $10.9M.
Stanley Druckenmiller first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Stanley Druckenmiller's Cidara Therapeutics position peaked at $10.9M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Duquesne Family Office's 13F filing for Q1 2026, filed 15 May 2026.